Prellis Biologics is a Biotech company based in Irvine, California. It has raised $50M in total funding. Latest round: Series C.
Prellis Biologics is a Biotech company based in Irvine, California. Prellis Biologics has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in August 2022. The round record for Prellis Biologics runs through 2022; nothing later has been disclosed. Investors on record include Bristol Myers Squibb, Sanofi. 2 distinct backers are named across the disclosed rounds.
We update the Prellis Biologics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Irvine and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026